Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
B. Braun Melsungen AG B. Braun Medical (Shanghai) International Trading Corp. Ltd. Shanghai Tigermed Consulting Co. Ltd |
---|---|
Information provided by: | B. Braun Melsungen AG |
ClinicalTrials.gov Identifier: | NCT00506246 |
The purpose of the study to compare Propofol-MCT/LCT with LCT in terms of their efficacy and safety during total intravenous anaesthesia
Condition | Intervention | Phase |
---|---|---|
General Anaesthesia Induction of Anaesthesia |
Drug: Propofol |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Bio-equivalence Study |
Official Title: | A Multi-Center, Randomized, Double-Blind, Positive Controlled Study to Evaluate the Efficacy and Safety of Propofol(Propofol®-Lipuro) in Total Intravenous Anaesthesia |
Estimated Enrollment: | 220 |
Study Start Date: | June 2007 |
Study Completion Date: | October 2007 |
Primary Completion Date: | October 2007 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Propofol MCT/LCT
|
Drug: Propofol
|
2: Active Comparator
Propofol LCT
|
Drug: Propofol
|
Propofol (chemical substance 2, 6-Diisopropylphenol) is a short-acting intravenous general anaesthetic which is used for induction and maintenance of a general anaesthesia, for long-term sedation of ventilated intensive care patients or for short-term sedation in diagnostic and surgical procedures. As an active substance propofol produces good and readily controlled anaesthesia with smooth and problem-free recovery both in adult patients and in children over 1 month of age. One potential advantage of this formulation is that the MCT/LCT-emulsion reduces pain on injection, a frequently reported adverse reaction with LCT-emulsions of propofol.
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
China | |
Zhongshan Hospital affiliated to Fudan University | |
Shanghai, China | |
Pekin Union Medical College Hospital | |
Beijing, China | |
Renji Hospital Affiliated to Shanghai Jiaotong University | |
Shanghai, China |
Principal Investigator: | Zhanggang Xue, Prof | Zhongshan Hospital affiliated to Fudan University |
Study ID Numbers: | 2006L00667 |
Study First Received: | July 24, 2007 |
Last Updated: | February 22, 2008 |
ClinicalTrials.gov Identifier: | NCT00506246 |
Health Authority: | China: State Food and Drug Administration |
anaesthesia |
Propofol |
Anesthetics, Intravenous Anesthetics, General Therapeutic Uses Hypnotics and Sedatives Physiological Effects of Drugs |
Central Nervous System Depressants Anesthetics Central Nervous System Agents Pharmacologic Actions |